Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Cancers|October 14, 2022
FOXC2 Promotes Vasculogenic Mimicry in Ovarian CancerMaria Sol Recouvreux, Jiangyong Miao, Maricel C Gozo, et al.
Gynecologic Oncology|May 23, 2026
Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survivalAlexandra H Smick, Natalia Zurek, Barbie Taylor-Harding, et al.
Plos One|March 6, 2009
CA125/MUC16 is dispensable for mouse development and reproductionDong-Joo Cheon, Ying Wang, Jian Min Deng, et al.
Biochemical and Biophysical Research Communications|June 7, 2015
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancerJing Huang, Lei Wang, Zhongyi Cong, et al.
Science Advances|April 17, 2024
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinomaAlexander M Xu, Marcela Haro, Ann E Walts, et al.
Cancer Research|October 16, 2010
Hippo pathway effector Yap is an ovarian cancer oncogeneChad A Hall, Runsheng Wang, Jiangyong Miao, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2007
HOXB13 promotes ovarian cancer progressionJiangyong Miao, Zuncai Wang, Heather Provencher, et al.
NPJ Precision Oncology|February 15, 2024
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancerYe Hu, Maria Sol Recouvreux, Marcela Haro, et al.
Pageof 14